Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

U.S. Life and Health Insurance Industry Analysis

UpdatedAug 22, 2026
DataAggregated Company Financials
Companies21
  • 7D-4.3%
  • 3M7.0%
  • 1Y13.8%
  • YTDn/a

Over the last 7 days, the Life and Health Insurance industry has dropped 4.4%, driven by pullbacks in MetLife and Aflac of 4.1% and 4.1%, respectively. This takes the industry's 12 month performance to a gain of 16%. Looking forward, earnings are forecast to grow by 7.9% annually.

Industry Valuation and Performance

Has the U.S. Life and Health Insurance Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sat, 22 Aug 2026US$267.0bUS$273.7bUS$21.1b15.7x12.7x1x
Mon, 20 Jul 2026US$277.2bUS$264.8bUS$18.7b14.7x14.8x1x
Wed, 17 Jun 2026US$261.4bUS$264.8bUS$18.7b15.4x14x1x
Fri, 15 May 2026US$248.8bUS$264.8bUS$18.7b13.9x13.3x0.9x
Sun, 12 Apr 2026US$235.9bUS$260.4bUS$16.6b15.2x14.2x0.9x
Tue, 10 Mar 2026US$232.7bUS$260.6bUS$16.6b14.6x14x0.9x
Thu, 05 Feb 2026US$241.2bUS$253.7bUS$20.7b12.7x11.7x1x
Sat, 03 Jan 2026US$249.2bUS$255.6bUS$19.7b12.9x12.6x1x
Mon, 01 Dec 2025US$245.1bUS$255.6bUS$19.7b12.4x12.4x1x
Wed, 29 Oct 2025US$243.1bUS$255.2bUS$16.2b12.5x15x1x
Fri, 26 Sep 2025US$253.1bUS$254.5bUS$15.7b13.2x16.2x1x
Sun, 24 Aug 2025US$252.3bUS$254.5bUS$15.7b14x16.1x1x
Tue, 22 Jul 2025US$242.3bUS$257.6bUS$18.1b12.1x13.4x0.9x
Thu, 19 Jun 2025US$222.6bUS$243.3bUS$17.6b12.1x12.7x0.9x
Sat, 17 May 2025US$231.2bUS$243.3bUS$17.6b12.6x13.1x1x
Mon, 14 Apr 2025US$218.6bUS$250.3bUS$22.4b10.1x9.8x0.9x
Wed, 12 Mar 2025US$232.8bUS$250.3bUS$22.4b10.3x10.4x0.9x
Fri, 07 Feb 2025US$237.7bUS$242.6bUS$18.1b13.1x13.1x1x
Sun, 05 Jan 2025US$231.5bUS$242.9bUS$14.3b13.8x16.2x1x
Tue, 03 Dec 2024US$252.1bUS$242.9bUS$14.3b14.7x17.7x1x
Thu, 31 Oct 2024US$239.5bUS$230.0bUS$17.1b13.4x14x1x
Sat, 28 Sep 2024US$242.9bUS$229.8bUS$16.6b13.3x14.6x1.1x
Mon, 26 Aug 2024US$231.3bUS$229.8bUS$16.6b12.8x13.9x1x
Wed, 24 Jul 2024US$228.1bUS$222.7bUS$14.7b10x15.5x1x
Fri, 21 Jun 2024US$216.1bUS$225.4bUS$14.8b10.5x14.6x1x
Sun, 19 May 2024US$220.0bUS$225.4bUS$14.8b10.4x14.8x1x
Tue, 16 Apr 2024US$206.4bUS$216.9bUS$10.3b15.8x20.1x1x
Thu, 14 Mar 2024US$217.1bUS$216.9bUS$10.2b15.8x21.2x1x
Sat, 10 Feb 2024US$211.3bUS$209.7bUS$8.1b12.2x26.1x1x
Mon, 08 Jan 2024US$258.5bUS$213.6bUS$2.7b13.6x95.5x1.2x
Wed, 06 Dec 2023US$250.7bUS$216.4bUS$1.6b13.2x153.9x1.2x
Fri, 03 Nov 2023US$237.1bUS$232.9b-US$176,908,374.0011.1x-1340.4x1x
Sun, 01 Oct 2023US$241.6bUS$238.9bUS$1.0b12.6x236.3x1x
Tue, 29 Aug 2023US$241.0bUS$238.9bUS$1.0b13.1x235.7x1x
Price to Earnings Ratio

235.7x


Total Market Cap: US$241.0bTotal Earnings: US$1.0bTotal Revenue: US$238.9bTotal Market Cap vs Earnings and Revenue0%0%0%
U.S. Life and Health Insurance Industry Price to Earnings3Y Average 38x202420252026
Current Industry PE
  • Investors are pessimistic on the American Life and Health Insurance industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 12.8x which is lower than its 3-year average PE of 38.2x.
  • The industry is trading close to its 3-year average PS ratio of 0.99x.
Past Earnings Growth
  • The earnings for companies in the Life and Health Insurance industry have grown 174% per year over the last three years.
  • Revenues for these companies have grown 4.6% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Comparison

How does U.S. Life and Health Insurance compare with similar industries?

US Market-1.53%
Financials-1.24%
Insurance-0.64%
Life and Health Insurance-4.26%
Insurance Brokers2.15%
Property and Casualty Insurance-0.45%
Reinsurance-0.93%
General Insurance-3.61%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
No data available

Latest News

FG
US$22.57
F&G Annuities & Life
7D
-17.7%
1Y
-36.1%
PRU
US$121.15
Prudential Financial
7D
-3.2%
1Y
10.2%
Narrative Update • Aug 20

PRU: Higher Earnings Hopes Will Sustain Overvaluation Risk Despite Japan Conduct Issues

Analysts have increased their fair value estimate for Prudential Financial to about $111 from roughly $107, reflecting a series of higher Street price targets that cite stronger sector valuations, slightly improved long-term earnings expectations, and company-specific cost savings. Analyst Commentary Recent research on Prudential Financial shows a cluster of higher price targets, but also a split in how comfortable analysts feel about execution and risk.
PFG
US$110.75
Principal Financial Group
7D
-2.8%
1Y
37.2%
Narrative Update • Aug 19

PFG: Future Capital Returns And Earnings Resilience Will Support Balanced Upside Potential

Analysts nudged the fair value estimate for Principal Financial Group higher to about $109.58 from roughly $107.33, citing updated revenue and valuation assumptions in recent price target revisions across the Street. Analyst Commentary Recent Street research on Principal Financial Group shows a mix of optimism and caution, with several firms lifting price targets while keeping a wide spread of ratings from Underperform to Overweight.
BNT
US$41.81
Brookfield Wealth Solutions
7D
-4.6%
1Y
-4.7%
GL
US$171.08
Globe Life
7D
-5.5%
1Y
21.1%
Narrative Update • Aug 11

GL: Future Buybacks And Earnings Guidance Will Support Share Price Upside

Analysts have nudged their price target on Globe Life from $215.00 to about $224.75. This reflects updated assumptions around fair value, discount rate, revenue growth, profit margin and future P/E that modestly adjust the risk and earnings profile in their models.
AFL
US$116.07
Aflac
7D
-4.4%
1Y
7.0%
MET
US$94.34
MetLife
7D
-3.4%
1Y
15.8%
Narrative Update • Aug 08

MET: Buybacks And Settlement Features Will Shape A Measured Future Risk Reward Balance

Analysts have lifted their price target on MetLife to $100.44 from $97.75, citing updated assumptions for fair value, discount rate, revenue growth, profit margin, and future P/E. These changes collectively support a slightly higher valuation framework.
UNM
US$87.77
Unum Group
7D
-6.0%
1Y
25.5%